Who makes [14C]TPN171H?

[14C]TPN171H is developed by Vigonvita Life Sciences.

Last reviewed 2026-04-19 · How we verify

[14C]TPN171H

Vigonvita Life Sciences · Phase 1 active Small molecule

At a glance

Generic name	[14C]TPN171H
Sponsor	Vigonvita Life Sciences
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]TPN171H CI brief — competitive landscape report
[14C]TPN171H updates RSS · CI watch RSS
Vigonvita Life Sciences portfolio CI